(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

COVIDSEQ

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: Estados Unidos

Snapshot rápido

COVIDSEQ

ST13

US500000088983895

Classe

1, 5

Pedido

88983895

Registro

6885352

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

50

Atualização mais recente

05/11/2025

Tipo de marca

Verbal

Classes Nice

1, 5

Data de depósito

24/04/2020

Data de registro

25/10/2022

Data de expiração

-

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

25/10/2022

Última transação

05/11/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

14/05/2020

Primeiro uso no comércio

09/06/2020

Código do desenho

4

Tipo de titular

03

Localização do titular

San Diego, CA

Examinador

HUSSAIN,TASNEEM

Unidade examinadora

M90

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Illumina, Inc.

Representantes

Susan M. Natland Baker & Hostetler LLP

Classificação técnica

Classes Nice

Classe 1Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Agentsreagentsassaysenzymesnucleotidesbufferschemical preparationsbiological preparations for scientific and research use; Diagnostic reagents and preparationsother than for medical or veterinary use; Kits comprised principally of reagents with a protocol for use thereof for non-medical purposes; Agentsreagentsassaysenzymesnucleotidesbufferschemical preparationsbiological preparations for scientific and research use in the fields of nucleic acid sequencinggenotypingdiagnosticsdiagnostic researchclinical researchdrug developmentpharmaceuticalslaboratory researchscientific researchmedical researchlife sciencesbiologymicrobiology and metagenomicsbiotechnologygenetic testinggeneticsnot for medical or veterinary purposes; Kits comprising nucleotidesreagentsenzymesagentsassaysbufferschemical preparationsbiological preparations for scientific and research use including in the fields of nucleic acid sequencinggenotypingdiagnosticsdiagnostic researchclinical researchdrug developmentpharmaceuticalslaboratory researchscientific researchmedical researchlife sciencesbiologymicrobiology and metagenomicsbiotechnologygenetic testinggeneticsnot for medical or veterinary purposes; all of the foregoing for the detection of or in the field of COVID-19

Classe 5

Diagnostic agentsreagentsassaysenzymesnucleotidesbufferschemical preparationsbiological preparations for medical use; Diagnostic reagents and preparations for medical use; Kits comprised principally of diagnostic reagents with a protocol for use thereof for medical purposes; Kits comprised of diagnostic nucleotidesreagentsenzymesagentsassaysbufferschemical preparationsbiological preparations for medical genetic testing and medical diagnostic purposes; diagnostic agentsreagentsassaysenzymesnucleotidesbufferschemical preparationsbiological preparations for medical use in the fields of medical diagnosticsclinical diagnosticsmedical forensicslaboratory medicinegenetic testinggenetics; all of the foregoing for the detection of or in the field of COVID-19

Publicações

Histórico de despachos e eventos da marca no USPTO.

50 publicações encontradas

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

29/10/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

29/10/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

29/10/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

29/10/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

29/10/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

29/10/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

25/10/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

25/10/2022

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

20/09/2022

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

19/09/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

19/09/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

19/09/2022

ALIE

ASSIGNED TO LIE

19/09/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/09/2022

EEXT

SOU TEAS EXTENSION RECEIVED

20/07/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/03/2022

GNRT

NON-FINAL ACTION E-MAILED

08/03/2022

CNRT

SU - NON-FINAL ACTION - WRITTEN

08/03/2022

SUPC

STATEMENT OF USE PROCESSING COMPLETE

03/03/2022

DPCC

DIVISIONAL PROCESSING COMPLETE

03/03/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/03/2022

IUAF

USE AMENDMENT FILED

16/02/2022

DRRR

DIVISIONAL REQUEST RECEIVED

16/02/2022

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

16/02/2022

EISU

TEAS STATEMENT OF USE RECEIVED

16/02/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/02/2022

EX1G

SOU EXTENSION 1 GRANTED

01/02/2022

EXT1

SOU EXTENSION 1 FILED

01/02/2022

EEXT

SOU TEAS EXTENSION RECEIVED

01/02/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

03/08/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/06/2021

PUBO

PUBLISHED FOR OPPOSITION

08/06/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

19/05/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/05/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

30/04/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

30/04/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

30/04/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

30/04/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

22/04/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

21/04/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

21/04/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

21/10/2020

GNRT

NON-FINAL ACTION E-MAILED

21/10/2020

CNRT

NON-FINAL ACTION WRITTEN

21/10/2020

DOCK

ASSIGNED TO EXAMINER

19/10/2020

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

09/07/2020

ALIE

ASSIGNED TO LIE

08/07/2020

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

25/06/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/05/2020

NWAP

NEW APPLICATION ENTERED

28/04/2020

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace COVIDSEQ ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.